NUZ 5.26% 20.0¢ neurizon therapeutics limited

Ann: Shareholder Update - Human & Canine Trials, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,667 Posts.
    lightbulb Created with Sketch. 111
    We have had patients humans and canines both now complete a trial with no side-effects. That is massively positive news.

    We are now aggressively trying to recruit more patients. Also a massive positive.

    Once we have more patients complete trials with no side effects which is likely then I assume we can test with higher dosages and hopefully 'healthier' patients.

    Don't underestimate the management/brains behind this company, things are flowing along nicely I think.
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $98.34M
Open High Low Value Volume
20.0¢ 20.5¢ 19.5¢ $86.20K 429.7K

Buyers (Bids)

No. Vol. Price($)
3 67508 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 36444 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.